Literature DB >> 9636935

Occupational upper extremity disorders in the federal workforce. Prevalence, health care expenditures, and patterns of work disability.

M Feuerstein1, V L Miller, L M Burrell, R Berger.   

Abstract

Upper extremity disorders (UEDs) account for a significant number of work-related illnesses in the US workforce. Little information exists on the distribution of UEDs, their associated health care and indemnity costs, or patterns of work disability. The study presented is an analysis of upper extremity claims within the federal workforce. In this study, the universe consisted of all claims accepted by the US Department of Labor, Office of Workers' Compensation Programs (OWCP), from October 1, 1993, through September 30, 1994. A total of 185,927 claims of notices of injury were processed during the study period, and of these, 8,147 or 4.4% had an UED diagnosis coded according to the International Classification of Diseases, Clinical Modification (ICD-9-CM). 5,844 claims involved a single UED diagnosis and were the only claims field by these employees between October 1, 1990, and September 30, 1994. These single claims with single diagnoses comprised the sample for further analysis. Mononeuritis and enthesopathies of the upper limb were the most common diagnoses, accounting for 43% and 31% of the claims, respectively. Women had a higher proportion of carpal tunnel syndrome, "unspecified" mononeuritis, and "unspecified" enthesopathies. The majority of claimants for both the mononeuritis- and enthesopathy-related diagnoses were between 31 and 50 years of age, received only health care benefits, and did not incur wage loss. Health care costs for mononeuritis and enthesopathy claims were $12,228,755 (M = $2,849). Carpal tunnel syndrome (CTS) and enthesopathy of the elbow were the most costly diagnoses, accounting for 57% and 16% of the total, respectively. Surgical services represented the highest expenditures in CTS claims. Physical therapy accounted for the majority of health care costs for enthesopathy cases. The mean number of workdays lost for CTS and enthesopathy claims were 84 and 79, and the average indemnity costs were $4,941 and $4,477, respectively. These findings indicate that while UEDs represent a relatively small percentage of all workers' compensation cases, the health care and indemnity costs are considerable. Also mean duration and pattern of work disability revealed that these disorders can result in chronic work disability similar to that observed in low back pain. The results highlight the need to determine whether interventions that account for the majority of costs significantly impact long-term outcomes. There is also a need to identify risk factors for prolonged disability in those who experience problems with delayed recovery.

Entities:  

Mesh:

Year:  1998        PMID: 9636935     DOI: 10.1097/00043764-199806000-00007

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  33 in total

Review 1.  Pathophysiological tissue changes associated with repetitive movement: a review of the evidence.

Authors:  Ann E Barr; Mary F Barbe
Journal:  Phys Ther       Date:  2002-02

2.  Changes in Physiotherapy Utilization in One Workforce: Implications for Accessibility among Canadian Working-Age Adults.

Authors:  Sheilah Hogg-Johnson; Donald C Cole; Hyunmi Lee; Dorcas E Beaton; Carol Kennedy; Peter Subrata
Journal:  Healthc Policy       Date:  2011-02

3.  Examining the association between musculoskeletal injuries and carpal tunnel syndrome in manual laborers.

Authors:  Michael S Cartwright; Samuel Yeboah; Francis O Walker; Daryl A Rosenbaum; Jill C Newman; Thomas A Arcury; Dana C Mora; Sara A Quandt
Journal:  Muscle Nerve       Date:  2016-01-05       Impact factor: 3.217

4.  A randomized trial of diagnostic ultrasound to improve outcomes in focal neuropathies.

Authors:  Michael S Cartwright; Leah P Griffin; Hugh Dowlen; Jessica M Bargoil; James B Caress; Zhongyu J Li; Anthony J Defranzo; Ethan R Wiesler; Christopher J Tuohy; Nikhil Balakrishnan; Joseph A Molnar; Vanessa Baute; L Andrew Koman; Gary G Poehling; Francis O Walker
Journal:  Muscle Nerve       Date:  2015-09-10       Impact factor: 3.217

5.  Upper extremity disorders in the workplace: costs and outcomes beyond the first return to work.

Authors:  Marjorie L Baldwin; Richard J Butler
Journal:  J Occup Rehabil       Date:  2006-09

6.  Perspectives from Employers, Insurers, Lawyers and Healthcare Providers on Factors that Influence Workers' Return-to-Work Following Surgery for Non-Traumatic Upper Extremity Conditions.

Authors:  Susan E Peters; Michel W Coppieters; Mark Ross; Venerina Johnston
Journal:  J Occup Rehabil       Date:  2017-09

7.  Treatments for carpal tunnel syndrome: who does what, when ... and why?

Authors:  Regina M Taylor-Gjevre; John A Gjevre; Lannae Strueby; Carol A J Boyle; Bindu Nair; John T Sibley
Journal:  Can Fam Physician       Date:  2007-07       Impact factor: 3.275

8.  A manual therapy intervention improves symptoms in patients with carpal tunnel syndrome: a pilot study.

Authors:  Susanna Maddali Bongi; Massimo Signorini; Massimo Bassetti; Angela Del Rosso; Martina Orlandi; Giuseppe De Scisciolo
Journal:  Rheumatol Int       Date:  2012-10-11       Impact factor: 2.631

9.  Optimal management of carpal tunnel syndrome.

Authors:  Shimpei Ono; Philip J Clapham; Kevin C Chung
Journal:  Int J Gen Med       Date:  2010-08-30

10.  bFGF and PDGF-BB for tendon repair: controlled release and biologic activity by tendon fibroblasts in vitro.

Authors:  Stavros Thomopoulos; Rosalina Das; Shelly Sakiyama-Elbert; Matthew J Silva; Nichole Charlton; Richard H Gelberman
Journal:  Ann Biomed Eng       Date:  2010-02       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.